Back to JPMORGAN CHASE & CO JPMORGAN CHASE & CO

CMNDCMND
2 quarters

Position history for JPMORGAN CHASE & COJPMORGAN CHASE & CO's holdings in CLEARMIND MEDICINE INC

No. JPMorgan Chase exited its CMND (Clearmind Medicine) position in Q1 2026. Its Q4 2025 13F listed 5 shares worth $9. JPMorgan Chase first reported CMND in Q4 2025 and held it in 1 quarterly 13F filing.

Final Value

$0

Final Shares

0

Total Value Change

-$9

Total Shares Change

-5

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q1
Latest
Exited
0
-100.0%
$00.0%$1.25
0
2025-Q4
New
5
-
$90.0%$144.80
17

Other major holders of CMND: XTX Topco Ltd, HRT FINANCIAL LP, UBS Group AG, ROYAL BANK OF CANADA

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used